Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTX-1955 CO2 challenge study in healthy participants
NL-OMON58686Phase 1Completed
- Sponsor
- Newleos Therapeutics
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of RO7308480 in generalized anxiety disorder (GAD), sponsored by Newleos Therapeutics. Started Aug 2025; status: completed.
02
Drugs
RO7308480
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NL-OMON58686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58686.